JNT-517

• UNSPSC Description:

  JNT-517 is an oral SLC6A19 allosteric inhibitor for the study of phenylketonuria (PKU)[1].

• Target Antigen:

  Biochemical Assay Reagents

• Type:

  Reference compound

• Related Pathways:

  Others

• Applications:

  Metabolism-protein/nucleotide metabolism

• Field of Research:

  Metabolic Disease

• Assay Protocol:

  https://www.medchemexpress.com/jnt-517.html

• Solubility:

  DMSO : 200 mg/mL (ultrasonic)

• Smiles:

  FC(C=C(C=C1)OC(F)(F)F)=C1CNC(N(C2CC2)[C@H]3CN(CCC3)C(N)=O)=O

• Molecular Weight:

  418.39

• References & Citations:

  [1]Dean G Brown, et al. Small molecule inhibitors of mammalian slc6a19 function. Patent WO2022192370A1.

• Shipping Conditions:

  Room Temperature

• Clinical Information:

  Phase 3

• CAS Number:

  2837993-05-0